ArticleDiabetes therapy : research, treatment and education of diabetes and related disorders2022

Long-Term Cost-Effectiveness Analysis of Once-Weekly Semaglutide versus Dulaglutide in Patients with Type 2 Diabetes with Inadequate Glycemic Control in China.

Zhen Ruan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.